Terms: = Colorectal cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Prognosis
52 results:
1. colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization.
Pei W; Wei K; Wu Y; Qiu Q; Zhu H; Mao L; Shi X; Zhang S; Shi Y; Tao S; Mao H; Pang S; Wang J; Liu M; Wang W; Yang Q; Chen C
Gene; 2023 Nov; 885():147692. PubMed ID: 37562585
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.
Jia Y; Yan Q; Zheng Y; Li L; Zhang B; Chang Z; Wang Z; Tang H; Qin Y; Guan XY
J Exp Clin Cancer Res; 2022 Sep; 41(1):287. PubMed ID: 36171622
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Mechanism of Integrin αvβ6 in Liver Metastasis of Colon cancer Based on SDF-1/cxcr4.
Shi J; Fan L; Li B; Pan H
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):88-95. PubMed ID: 35818267
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell N
Gao Y; Wang H; Chen S; An R; Chu Y; Li G; Wang Y; Xie X; Zhang J
J Transl Med; 2022 May; 20(1):197. PubMed ID: 35509079
[TBL] [Abstract] [Full Text] [Related]
5. SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the cxcr4/CXCL12 axis.
Fang H; Huang Y; Luo Y; Tang J; Yu M; Zhang Y; Zhong M
Cell Immunol; 2022 Jan; 371():104458. PubMed ID: 34847407
[TBL] [Abstract] [Full Text] [Related]
6. Expression of Four Autophagy-Related Genes Accurately Predicts the prognosis of Gastrointestinal cancer in Asian Patients.
Tang H; Liang Y; Xu S; Xia R; Shen J; Zhang Y; Gong X; Min Y; Zhang D; Zhao T; Wang S; Zhang Y; Wang C
Dis Markers; 2021; 2021():7253633. PubMed ID: 34484469
[TBL] [Abstract] [Full Text] [Related]
7. A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal cancer.
Dalle Fratte C; Mezzalira S; Polesel J; De Mattia E; Palumbo A; Buonadonna A; Palazzari E; De Paoli A; Belluco C; Canzonieri V; Toffoli G; Cecchin E
Oncol Res; 2022 Jan; 28(9):847-855. PubMed ID: 34108073
[TBL] [Abstract] [Full Text] [Related]
8. The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives.
Majidpoor J; Mortezaee K
Clin Immunol; 2021 May; 226():108707. PubMed ID: 33662590
[TBL] [Abstract] [Full Text] [Related]
9. Cisatracurium regulates the cxcr4/let-7a-5p axis to inhibit colorectal cancer progression by suppressing TGF-β/SMAD2/3 signalling.
Xia YZ; Shan GF; Yang H; Zha J; Wang L; Chen JM; Zhang XS
Chem Biol Interact; 2021 Apr; 339():109424. PubMed ID: 33617803
[TBL] [Abstract] [Full Text] [Related]
10. CXCL12-mediated HOXB5 overexpression facilitates colorectal cancer metastasis through transactivating cxcr4 and ITGB3.
Feng W; Huang W; Chen J; Qiao C; Liu D; Ji X; Xie M; Zhang T; Wang Y; Sun M; Tian D; Fan D; Nie Y; Wu K; Xia L
Theranostics; 2021; 11(6):2612-2633. PubMed ID: 33456563
[No Abstract] [Full Text] [Related]
11. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.
Zhang GF; Qiu L; Yang SL; Wu JC; Liu TJ
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32140709
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic colorectal cancer Patients.
Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
[TBL] [Abstract] [Full Text] [Related]
13. Nanostructured toxins for the selective destruction of drug-resistant human cxcr4
Serna N; Álamo P; Ramesh P; Vinokurova D; Sánchez-García L; Unzueta U; Gallardo A; Céspedes MV; Vázquez E; Villaverde A; Mangues R; Medema JP
J Control Release; 2020 Apr; 320():96-104. PubMed ID: 31931052
[TBL] [Abstract] [Full Text] [Related]
14. cxcr4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
[No Abstract] [Full Text] [Related]
15. cxcr4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis.
Jiang Q; Sun Y; Liu X
Biomarkers; 2019 Sep; 24(6):510-516. PubMed ID: 31244335
[No Abstract] [Full Text] [Related]
16. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and colorectal Liver Metastasis.
Jiao X; Shu G; Liu H; Zhang Q; Ma Z; Ren C; Guo H; Shi J; Liu J; Zhang C; Wang Y; Gao Y
J Histochem Cytochem; 2019 May; 67(5):299-308. PubMed ID: 30633620
[TBL] [Abstract] [Full Text] [Related]
17. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
Cabrero-de Las Heras S; Martínez-Balibrea E
World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
[TBL] [Abstract] [Full Text] [Related]
18. cxcr4 overexpression is correlated with poor prognosis in colorectal cancer.
Xu C; Zheng L; Li D; Chen G; Gu J; Chen J; Yao Q
Life Sci; 2018 Sep; 208():333-340. PubMed ID: 29719205
[TBL] [Abstract] [Full Text] [Related]
19. Phosphorylated cxcr4 expression has a positive prognostic impact in colorectal cancer.
Weixler B; Renetseder F; Facile I; Tosti N; Cremonesi E; Tampakis A; Delko T; Eppenberger-Castori S; Tzankov A; Iezzi G; Kettelhack C; Soysal SD; von Holzen U; Spagnoli GC; Terracciano L; Tornillo L; Droeser RA; Däster S
Cell Oncol (Dordr); 2017 Dec; 40(6):609-619. PubMed ID: 28936810
[TBL] [Abstract] [Full Text] [Related]
20. Role of cxcr4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
[TBL] [Abstract] [Full Text] [Related]
[Next]
